Volume : 12, Issue : 10, October – 2025

Title:

TRANSFEROSOMAL NANOPARTICLES FOR BACTERIAL MENINGITIS – A COMPREHENSIVE REVIEW

Authors :

Sobhitha B*, Archana A S, Dr.Keerthi G S Nair , Dr.John Wesley I, Dr.Mathan S, Prof. Dr. Shaiju S Dharan

Abstract :

Meningitis is an inflammation of the protective membranes called meninges and fluid adjacent the brain and spinal cord. The inflammatory progression expands all through subarachnoid space of the brain and spinal cord and occupies the ventricles. The pathogens like bacteria, fungi, viruses, or parasites are main sources of infection causing meningitis. Bacterial meningitis is a life-threatening health problem that which needs instantaneous apprehension and treatment. Nesseria meningitidis, Streptococcus pneumoniae, and Haemophilus flu are major widespread factors causing bacterial meningitis. The conventional drug delivery approaches encounter difficulty in crossing this blood-brain barrier (BBB) and therefore are insufficient to elicit the desired pharmacological effect as required for treatment of meningitis. Therefore, application of nanoparticle- based drug delivery systems has become imperative for successful dealing with this deadly disease. The nanoparticles have ability to across BBB via four important transport mechanisms, i.e., paracellular transport, transcellular (transcytosis), endocytosis (adsorptive transcytosis), and receptor-mediated transcytosis. In this review, we reminisce distinctive symptoms of meningitis, and provide an overview of various types of bacterial meningitis, with a focus on its epidemiology, pathogenesis, and pathophysiology. This review describes conventional therapeutic approaches for treatment of meningitis and the problems encountered by them while transmitting across tight junctions of BBB. The nanotechnology approaches like functionalized polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carrier, nanoemulsion, liposomes, transferosomes, and carbon nanotubes which have been recently evaluated for treatment or detection of bacterial meningitis have been focused. This review has also briefly summarized the recent patents and clinical status of therapeutic modalities for meningitis.
Keywords: Transferosome, Nanoparticles, Meningitis, Inflammation

Cite This Article:

Please cite this article in press Sobhitha B et al., Transferosomal Nanoparticles For Bacterial Meningitis – A Comprehensive Review, Indo Am. J. P. Sci, 2025; 12(10).

REFERENCES:

1 Opatha SA, Titapiwatanakun V, Chutoprapat R. Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020 Sep;12(9):855.
2 Sharma N, Zahoor I, Sachdeva M, Subramaniyan V, Fuloria S, Fuloria NK, Naved T, Bhatia S, Al-Harrasi A, Aleya L, Bungau S. Deciphering the role of nanoparticles for management of bacterial meningitis: an update on recent studies. Environmental Science and Pollution Research. 2021 Nov 1:1-8.
3 Griffiths MJ, McGill F, Solomon T. Management of acute meningitis. Clinical Medicine. 2018 Apr 1;18(2):164-9.
4 Sachan R., Parashar T, Vishal Singh S., Singh G., Tyagi S., Pateal C., Gupta A., “Transfersomes: A Novel Tool For Transdermal Drug Delivery System” International Journal of research and Development in Pharmacy and Life Sciences, 2013; 2(2): 309-316.
5 Chaurasiya P., Ganju E., Upmanyu N., Ray S.K., Jain P. Transfersomes: A novel technique for transdermal drug delivery. J. Drug Deliv. Ther. 2019;9:279-285. doi: 10.22270/jddt.v9i1.2198.
6 Malakar J, Sen SO, Nayak AK, Sen KK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi pharmaceutical journal. 2012 Oct 1;20(4):355-63.
7 Priyanka K, Singh S. A review on skin targeted delivery of bioactives as ultradeformable vesicles: Overcoming the penetration problem. Current drug targets. 2014 Feb 1;15(2):184-98.
8 World Health Organization. Investing to defeat meningitis and beyond. World Health Organization; 2024 Apr 24.
9 Anusha V. Transferosomes-A Novel Vesicular System. Research Journal of Pharmaceutical Dosage Forms and Technology. 2014;6(4):286-91.
10 Pharmaceutical product development, N K Jain; page no:237, 451-452.
11 Rajkumar J, Lakshmi RS, Vineesha S. A New Approach to Transdermal Drug Delivery Using Transfersomes-Based Nanoencapsulation: A Research Update. Asian Journal of Pharmaceutical Research and Development. 2022 Feb 15;10(1):64-70.
12 Kumar R, Philip A. Modified Transdermal Technologies: Breaking the barriers of drug permeation via skin. Trop J Pharm Res 2007;6:633-44.
13 Patel SN, Patel N, Patel K.R., Patel N.M. “A Vesicular Transdermal Delivery System For enhance Drug Permeation-Ethosomes and Transfeosomed” Inter-national Pharmaceutical Sciencia, 2012; 2(2).
14 Das B, Nayak AK, Mallick S. Transferosomes: a novel nanovesicular approach for drug delivery. InSystems of nanovesicular drug delivery 2022 Jan 1 (pp. 103-114). Academic Press.1
15 Reshmy Rajan, Shoma Jose, and Deepa T. Vasudevan. Transferosomes – A ve- sicular transdermal delivery system for enhanced drug permeation Journal of Advanced Pharmaceutical Technology & Research. 2011; 138-14311
16 Reddy YD, Sravani AB, Ravisankar V, Prakash PR, Reddy YS, Bhaskar NV. Transferosomes a novel vesicular carrier for transdermal drug delivery system.J. Innov. Pharm. Biol. Sci. 2015;2(2):193-208.
17 Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: A novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Indian J Pharm Sci 2004;66:72-81.
18 Dave V., Kumar D., Lewis S., Paliwal S., “Ethosome for Enhanced Transdermal Drug Delivery of Aceclofenac” International Journal of Drug Delivery, 2010; 2: 81-92,
19 Patel R., Singh S.K., Singh. S, Sheth N.R., Gendle R. “Development and Characterization of Curcumim Loaded Transfersome for Transdermal Deliv- ery” journal of pharmaceutical research and science, 2009; 1(4): 71-80.
20 Vyas SP, Khar RK. Targeted and controlled drug delivery. 1st Ed Delhi: CBS Publishers; 2002. p. 219-43.
21 Gavali SM, Pacharane SS, Jadhav KR, Kadam VJ. Clinical P transfersome: a new technique for transdermal drug delivery. International Journal of Research in Pharmacy and Chemistry. 2011;1(3):735-40.
22 Chien YW. Logics of transdermal controlled drug administration. Drug Dev Ind Pharm 1983;9:497-520.
23 Modi CD and Bharadia PD. Transfersomes: New Dominants for Trans- dermal Drug Delivery. Am J PharmTech Res. 2012; 2(3): 71-91. 2
24 https://www.asynt.com/blog/what-is-a-rotary-evaporator/
25 https://www.differencebetween.com/difference-between-probe-sonicator- and-bath-sonicator/amp/
26 https://m.indiamart.com/proddetail/probe-sonicator-q500-4923288862.html
27 https://images.app.goo.gl/CqC4EybAsdRFQLZE6
28 https://en.m.wikipedia.org/wiki/Centrifuge#/media/File%3ATabletop_centrifu ge.jpg
29 https://www.ncbi.nlm.nih.gov/books/NBK459360/
30 https://www.mayoclinic.org/diseases-conditions/meningitis/symptoms- causes/syc-20350508
31 Joseph SK, Arya MA, Thomas S, Nair SC. Nanomedicine as a future therapeutic approach for treating meningitis. Journal of Drug Delivery Science and Technology. 2022 Jan 1;67:102968.
32 Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-Kubati SS. Recent progress in nanocarriers for direct nose to brain drug delivery. Journal of Drug Delivery Science and Technology. 2021 Aug 1;64:102642.
33 Schaad UB. Treatment of bacterial meningitis. European Journal of Clinical Microbiology. 1986 Oct;5:492-7.